BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND CALCB, Calcitonin AND Clinical Outcome
14 results:

  • 1. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on clinical Behavior of Medullary Thyroid Carcinoma.
    Mishra V; Kowtal P; Rane P; Sarin R
    Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
    Rusinek D; Chmielik E; Krajewska J; Jarzab M; Oczko-Wojciechowska M; Czarniecka A; Jarzab B
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829399
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Surgical Treatment of Medullary Thyroid Cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
    Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.
    Yang JH; Lindsey SC; Camacho CP; Valente FO; Germano-Neto F; Machado AL; Mamone MC; Brodskyn F; Biscolla RP; Tuttle RM; Dias-da-Silva MR; Maciel RM
    Clin Endocrinol (Oxf); 2015 Dec; 83(6):938-42. PubMed ID: 25376110
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
    Salaun PY; Campion L; Bournaud C; Faivre-Chauvet A; Vuillez JP; Taieb D; Ansquer C; Rousseau C; Borson-Chazot F; Bardet S; Oudoux A; Cariou B; Mirallié E; Chang CH; Sharkey RM; Goldenberg DM; Chatal JF; Barbet J; Kraeber-Bodéré F
    J Nucl Med; 2012 Aug; 53(8):1185-92. PubMed ID: 22743249
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Vandetanib: in medullary thyroid cancer.
    Frampton JE
    Drugs; 2012 Jul; 72(10):1423-36. PubMed ID: 22715896
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?
    Bümming P; Ahlman H; Nilsson B; Nilsson O; Wängberg B; Jansson S
    Langenbecks Arch Surg; 2008 Sep; 393(5):699-703. PubMed ID: 18626656
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.
    Grozinsky-Glasberg S; Benbassat CA; Tsvetov G; Feinmesser R; Peretz H; Shimon I; Lapidot M
    Thyroid; 2007 Jun; 17(6):549-56. PubMed ID: 17614776
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
    Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
    Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence.
    Romei C; Elisei R; Pinchera A; Ceccherini I; Molinaro E; Mancusi F; Martino E; Romeo G; Pacini F
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1619-22. PubMed ID: 8636377
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Immunohistochemical and flow cytometric study of neuroendocrine carcinoma of the skin.
    Fukunaga M; Shinozaki N
    Pathol Int; 1995 Jul; 45(7):513-9. PubMed ID: 7551012
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.